HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Munehide Matsuhisa Selected Research

Inflammation (Inflammations)

10/2023Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study.
1/2020Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients.
7/2019Clinical impact of sarcopenia and dynapenia on diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Munehide Matsuhisa Research Topics

Disease

45Type 2 Diabetes Mellitus (MODY)
02/2024 - 07/2002
28Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2024 - 08/2002
27Insulin Resistance
12/2019 - 02/2003
15Hypoglycemia (Reactive Hypoglycemia)
04/2024 - 01/2014
13Atherosclerosis
10/2023 - 03/2005
12Carotid Artery Diseases
11/2023 - 08/2002
11Hyperglycemia
02/2024 - 02/2003
8Diabetic Nephropathies (Diabetic Nephropathy)
11/2023 - 11/2010
8Diabetes Mellitus
10/2023 - 09/2011
6Body Weight (Weight, Body)
02/2024 - 11/2007
6Diabetic Angiopathies (Diabetic Angiopathy)
09/2019 - 10/2005
4Albuminuria
10/2023 - 02/2011
4Diabetes Complications
10/2023 - 09/2008
4Glucose Intolerance
12/2019 - 01/2002
3Inflammation (Inflammations)
10/2023 - 07/2019
3Sarcopenia
01/2023 - 09/2019
3Cardiovascular Diseases (Cardiovascular Disease)
06/2016 - 02/2011
3Hypertension (High Blood Pressure)
01/2016 - 08/2008
3Diabetic Retinopathy (Retinopathy, Diabetic)
02/2013 - 07/2008
3Obesity
07/2007 - 06/2004
2Arteriosclerosis
10/2023 - 01/2016
2Diabetic Foot
10/2023 - 09/2011
2Non-alcoholic Fatty Liver Disease
08/2023 - 01/2014
2Chronic Renal Insufficiency
01/2020 - 01/2020
2Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 12/2019
2Infections
01/2020 - 08/2008
2Muscle Weakness
07/2019 - 05/2017
2Neoplasms (Cancer)
09/2017 - 01/2014
2Dyslipidemias (Dyslipidemia)
01/2016 - 01/2014
2Hyperinsulinism (Hyperinsulinemia)
09/2005 - 06/2004
1Weight Loss (Weight Reduction)
11/2023
1Proteinuria
10/2023
1Foot Ulcer
10/2023
1Peripheral Nervous System Diseases (PNS Diseases)
10/2023
1Ulcer
10/2023
1Contact Dermatitis (Eczema, Contact)
09/2023
1Fibrosis (Cirrhosis)
08/2023
1COVID-19
08/2023
1Hypertrophy
01/2023

Drug/Important Bio-Agent (IBA)

37Insulin (Novolin)FDA Link
04/2024 - 02/2003
32Glucose (Dextrose)FDA LinkGeneric
10/2023 - 01/2002
14Biomarkers (Surrogate Marker)IBA
10/2023 - 08/2008
10Blood Glucose (Blood Sugar)IBA
07/2021 - 10/2004
8Advanced Glycation End ProductsIBA
11/2023 - 11/2005
7Insulin Glargine (Lantus)FDA Link
02/2024 - 12/2016
7AlbuminsIBA
10/2023 - 07/2008
6AdiponectinIBA
01/2023 - 07/2007
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
04/2024 - 07/2008
5Glucagon (Glukagon)FDA Link
02/2024 - 11/2007
5Hypoglycemic Agents (Hypoglycemics)IBA
04/2023 - 01/2018
4Sodium-Glucose Transporter 2 InhibitorsIBA
11/2023 - 01/2016
4Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2005
4Pioglitazone (Actos)FDA Link
01/2014 - 04/2007
3DNA (Deoxyribonucleic Acid)IBA
07/2022 - 01/2002
3Indicators and Reagents (Reagents)IBA
02/2013 - 02/2008
3human esRAGE proteinIBA
05/2009 - 11/2005
3JNK Mitogen-Activated Protein KinasesIBA
01/2006 - 10/2004
2ipragliflozinIBA
11/2023 - 01/2016
2Fatty Acid-Binding ProteinsIBA
11/2023 - 12/2021
2AndrogensIBA
11/2023 - 01/2016
2SodiumIBA
10/2023 - 01/2018
2LipidsIBA
10/2023 - 02/2011
2Heparin Cofactor IIIBA
08/2023 - 12/2021
2ThrombinFDA Link
08/2023 - 12/2021
2Glucagon-Like Peptide 1 (GLP 1)IBA
04/2023 - 10/2018
2EnzymesIBA
01/2023 - 03/2016
2Testosterone (Sustanon)FDA Link
01/2019 - 04/2007
2Hemoglobins (Hemoglobin)IBA
01/2018 - 10/2005
2Sitagliptin Phosphate (Januvia)FDA Link
11/2017 - 06/2016
2CalciumIBA
01/2013 - 01/2009
2CopperIBA
01/2013 - 01/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2010 - 01/2009
2Sucrose (Saccharose)IBA
01/2009 - 02/2008
2Molecular Chaperones (Chaperone, Molecular)IBA
03/2005 - 01/2005
2Oxygen (Dioxygen)IBA
03/2005 - 01/2005
2AntioxidantsIBA
02/2005 - 07/2002
1Insulin SecretagoguesIBA
02/2024
1Syntex adjuvant formulationIBA
11/2023
1Dehydroepiandrosterone SulfateIBA
11/2023
1dasiglucagonIBA
11/2023
1ReninIBA
10/2023
1AngiotensinsIBA
10/2023
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2023
1NAD (NADH)IBA
10/2023
1Proteinase-Activated ReceptorsIBA
08/2023
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2023
1Whey ProteinsIBA
01/2023
1Antigen-Antibody Complex (Immune Complex)IBA
01/2023
1CreatinineIBA
12/2021
1Insulin-Like Growth Factor I (IGF-1)IBA
09/2021
1Phosphates (Orthophosphate)IBA
09/2021

Therapy/Procedure

16Glycemic Control
04/2024 - 07/2008
12Therapeutics
10/2018 - 06/2005
7Injections
02/2024 - 10/2005
3Communication Aids for Disabled (TDD)
02/2022 - 11/2012
2Transplantation
12/2019 - 08/2008
2Drug Therapy (Chemotherapy)
05/2018 - 03/2018
2Insulin Infusion Systems
03/2017 - 01/2014
2Kidney Transplantation
11/2010 - 08/2008
1Aftercare (After-Treatment)
10/2023